Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-001959

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 478,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lettmann Jason · CHIEF EXECUTIVE OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-21 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +478,000 478,000 D
Loading xslF345X05/form4-01232025_110159.xml…